Evonik Industries AG (EVK):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Evonik Industries AG (EVK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9819
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemicals company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets, including adhesives and sealants, automotive, agriculture, coatings, composites, construction, design, electronics and telecommunications, environment and utilities, food, feed, plastics, pharmaceuticals and others. Evonik also offers process technology, technical, logistics and engineering services. It operates major production, facilities in Germany, Belgium, the US China, Singapore and other countries. The company has operational presence in North America, Asia, Africa, South America, Europe and other countries. Evonik is headquartered in Essen, Nordrhein-Westfalen, Germany.

Evonik Industries AG (EVK) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evonik Industries AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evonik Industries AG, Medical Devices Deals, 2012 to YTD 2018 9
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evonik Industries AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Evonik Industries to Acquire Technology Package from METabolic Explorer 11
Venture Financing 12
Numaferm Raises Additional Funds through Seed Financing 12
JeNaCell Raises Funds in Series A Financing 13
Partnerships 14
BioDelivery Sciences Enters into Co-Development Agreement with Evonik 14
Colorcon Enters Into Co-Marketing Agreement With Evonik Industries For Acryl-EZE 15
DiFusion Technologies Enters Into Co-Development Agreement With Evonik Degussa For CleanFUZE 16
Losan Pharma Enters into Agreement with Evonik Industries 17
Evonik Industries Enters Into Co-Development Agreement With Brain 18
Debt Offering 19
Evonik Industries Raises USD559.3 Million in Private Placement of 0.75% Bonds Due 2028 19
Evonik Industries Raises USD727 Million in Private Placement of Bonds Due 2021 20
Evonik Industries Raises USD839 Million in Private Placement of 0.375% Bonds Due 2024 21
Asset Transactions 22
Deb Group Acquires Stoko Professional Skin Care Business From Evonik 22
Acquisition 23
Evonik Industries Acquires Transferra Nanosciences 23
Evonik Industries AG – Key Competitors 24
Evonik Industries AG – Key Employees 25
Evonik Industries AG – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 28
Recent Developments 29
Strategy And Business Planning 29
Jun 27, 2017: Evonik Expands North American Contract Development and Manufacturing Capabilities for Advanced Injectables 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Evonik Industries AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evonik Industries AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evonik Industries AG, Deals By Therapy Area, 2012 to YTD 2018 8
Evonik Industries AG, Medical Devices Deals, 2012 to YTD 2018 9
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evonik Industries to Acquire Technology Package from METabolic Explorer 11
Numaferm Raises Additional Funds through Seed Financing 12
JeNaCell Raises Funds in Series A Financing 13
BioDelivery Sciences Enters into Co-Development Agreement with Evonik 14
Colorcon Enters Into Co-Marketing Agreement With Evonik Industries For Acryl-EZE 15
DiFusion Technologies Enters Into Co-Development Agreement With Evonik Degussa For CleanFUZE 16
Losan Pharma Enters into Agreement with Evonik Industries 17
Evonik Industries Enters Into Co-Development Agreement With Brain 18
Evonik Industries Raises USD559.3 Million in Private Placement of 0.75% Bonds Due 2028 19
Evonik Industries Raises USD727 Million in Private Placement of Bonds Due 2021 20
Evonik Industries Raises USD839 Million in Private Placement of 0.375% Bonds Due 2024 21
Deb Group Acquires Stoko Professional Skin Care Business From Evonik 22
Evonik Industries Acquires Transferra Nanosciences 23
Evonik Industries AG, Key Competitors 24
Evonik Industries AG, Key Employees 25
Evonik Industries AG, Subsidiaries 26
Evonik Industries AG, Joint Venture 28

List of Figures
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evonik Industries AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Evonik Industries AG (EVK):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Euromoney Institutional Investor PLC (ERM):企業の財務・戦略的SWOT分析
    Euromoney Institutional Investor PLC (ERM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Span-America Medical Systems Inc (SPAN):企業の財務・戦略的SWOT分析
    Summary Span-America Medical Systems Inc (Span-America), a subsidiary of Savaria Corp, is a medical device company that designs and manufactures pressure management and patient positioning products. The company offers products such as surfaces, seat cushions, patient positioners, skin care products, …
  • Biosensors International Group Ltd:企業の戦略的SWOT分析
    Biosensors International Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Takeda Pharmaceuticals USA Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • EnerSys (ENS):電力:M&Aディール及び事業提携情報
    Summary EnerSys is a provider of stored energy solutions. It manufactures, markets, and distributes reserve power and motive power batteries, power equipment, battery accessories, battery chargers, and outdoor equipment enclosure solutions. The company also related aftermarket and customer-support s …
  • Greif, Inc. (GEF):企業の財務・戦略的SWOT分析
    Greif, Inc. (GEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • International Drug Development Institute-製薬・医療分野:企業M&A・提携分析
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical and …
  • Mercer LLC:企業の戦略的SWOT分析
    Mercer LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Hewlett Packard Enterprise Co (HPE):企業の財務・戦略的SWOT分析
    Hewlett Packard Enterprise Co (HPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lagardere SCA:企業の戦略・SWOT・財務情報
    Lagardere SCA - Strategy, SWOT and Corporate Finance Report Summary Lagardere SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kuwait National Petroleum Co:企業の戦略・SWOT・財務情報
    Kuwait National Petroleum Co - Strategy, SWOT and Corporate Finance Report Summary Kuwait National Petroleum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Incitec Pivot Ltd (IPL):企業の財務・戦略的SWOT分析
    Incitec Pivot Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Fluidic Analytics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Fluidic Analytics Ltd (Fluidic Analytics) is a biotechnology company that offers diagnostic tools to sequence and characterize proteins in laboratory, medical and consumer applications. The company offers Flow Mk-1 and Flow Mk-2 products. Flow Mk-1 is a lab instrument, which comprises dispos …
  • Avantec Vascular Corp:企業の製品パイプライン分析2018
    Summary Avantec Vascular Corp (Avantec Vascular), a subsidiary of Goodman Co Ltd, is a medical device company that develops cardiovascular interventional and peripheral vascular devices. The company's products comprise balloon catheter, aspiration catheter, device delivery system, micro catheter, gu …
  • UCL Business PLC:製薬・医療:M&Aディール及び事業提携情報
    Summary UCL Business PLC (UCLB), a subsidiary of University College London is a technology transfer company that supports and markets research and innovations. The company offers licensing technologies and innovations, creates shared risk joint venture businesses, and promotes and supports the trans …
  • Cullinan Holdings Limited:企業の戦略・SWOT・財務分析
    Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Physio-Control Inc-医療機器分野:企業M&A・提携分析
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Bain Capital LLC is a medical device company that offers development, manufacturing, sale and service of emergency medical response products. The company provides pre-hospital, hospital, military, and accessory and disposable products. Its …
  • Edison SpA:企業の発電所・SWOT分析2018
    Edison SpA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Mayo Clinic:製薬・医療:M&Aディール及び事業提携情報
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Adana Cimento Sanayii Tas
    Adana Cimento Sanayii Tas - Strategy, SWOT and Corporate Finance Report Summary Adana Cimento Sanayii Tas - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆